![Charles Pitman-King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Charles Pitman-King is currently VP of European Pharmaceuticals Equity Research at Barclays Capital Securities Ltd. since 2022.
Formerly, Mr. Pitman-King was an Equity Research Analyst at Rothschild & Co Global Markets Solutions Ltd. from 2016 to 2022.
Postes actifs de Charles Pitman-King
| Sociétés | Poste | Début |
|---|---|---|
Barclays Capital Securities Ltd.
 Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/09/2022 |
Anciens postes connus de Charles Pitman-King
| Sociétés | Poste | Fin |
|---|---|---|
Redburn (Europe) Ltd.
 Redburn (Europe) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/07/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Barclays Capital Securities Ltd.
Barclays Capital Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Redburn (Europe) Ltd.
Redburn (Europe) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
